During the last three months, 5 analysts shared their evaluations of CytoSorbents (NASDAQ:CTSO), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.2, a high estimate of $10.00, and a low estimate of $1.00. Witnessing a positive shift, the current average has risen by 5.81% from the previous average price target of $7.75.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of CytoSorbents among financial experts becomes clear...
Login or create a forever free account to read this news
Sign up/Log in
